Core Scientific (NASDAQ:CORZ) Reaches New 12-Month High – What’s Next?

Posted by Stanley Muller on May 16th, 2026

Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $25.07 and last traded at $24.8590, with a volume of 7274574 shares trading hands. The stock had previously closed at $24.00.

Wall Street Analyst Weigh In

Several research analysts have recently commented on CORZ shares. BTIG Research lifted their target price on Core Scientific from $23.00 to $33.00 and gave the stock a “buy” rating in a research note on Wednesday. Cantor Fitzgerald raised their price target on Core Scientific from $25.00 to $29.00 and gave the company an “overweight” rating in a report on Thursday, April 9th. LADENBURG THALM/SH SH reduced their price objective on shares of Core Scientific from $24.50 to $23.75 and set a “buy” rating for the company in a research report on Tuesday, March 3rd. HC Wainwright reiterated a “buy” rating and issued a $25.00 price objective on shares of Core Scientific in a report on Tuesday, March 3rd. Finally, Wall Street Zen raised shares of Core Scientific to a “sell” rating in a research report on Saturday, March 14th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Core Scientific presently has an average rating of “Moderate Buy” and a consensus target price of $28.14.

Check Out Our Latest Report on CORZ

Core Scientific Price Performance

The company has a market cap of $7.70 billion, a price-to-earnings ratio of -21.24 and a beta of 5.45. The firm has a 50-day moving average price of $18.57 and a 200 day moving average price of $17.71.

Core Scientific (NASDAQ:CORZ – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported ($1.06) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($1.04). The company had revenue of $115.24 million during the quarter, compared to analyst estimates of $117.04 million. During the same period in the prior year, the firm posted $1.25 earnings per share. The company’s revenue was up 44.9% compared to the same quarter last year. On average, equities analysts anticipate that Core Scientific, Inc. will post 0.11 EPS for the current fiscal year.

Insider Activity

In related news, insider Todd M. Duchene sold 10,000 shares of the company’s stock in a transaction dated Monday, May 4th. The shares were sold at an average price of $20.86, for a total value of $208,600.00. Following the transaction, the insider directly owned 1,980,348 shares in the company, valued at approximately $41,310,059.28. This represents a 0.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders have sold a total of 50,000 shares of company stock valued at $933,400 over the last three months. Insiders own 1.70% of the company’s stock.

Institutional Trading of Core Scientific

A number of institutional investors have recently bought and sold shares of the business. FNY Investment Advisers LLC bought a new stake in shares of Core Scientific in the fourth quarter valued at approximately $1,252,000. Kintayl Capital LP bought a new position in Core Scientific during the 3rd quarter worth $10,227,000. Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Core Scientific by 39.9% during the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 452,806 shares of the company’s stock worth $8,123,000 after acquiring an additional 129,133 shares during the period. Vanguard Group Inc. raised its holdings in Core Scientific by 18.7% in the 4th quarter. Vanguard Group Inc. now owns 33,960,320 shares of the company’s stock valued at $494,462,000 after acquiring an additional 5,359,710 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd raised its holdings in Core Scientific by 87.4% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 668,435 shares of the company’s stock valued at $11,992,000 after acquiring an additional 311,813 shares in the last quarter.

About Core Scientific

(Get Free Report)

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.